On November 9, ISDA sent a paper to the European Commission and UK Financial Conduct Authority recommending that over-the-counter (OTC) derivatives are identified using unique product identifiers (UPIs) for EU and UK transparency requirements, augmented with some key trade-level attributes (known as UPI+). ISDA believes this would be more appropriate than ISINs because it would enable users to aggregate and perform meaningful analysis on instrument pricing across the market. These additional attributes would ensure OTC derivatives could be identified and aggregated in a way that is useful to market participants while providing sufficient granularity to distinguish between different products.
Documents (1) for ISDA Paper on Unique Product Identifiers
Latest
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
ISDA Feedback on Identifying Reference Data
On July 20, ISDA submitted feedback to the European Securities and Markets Authority (ESMA) on draft Level 3 guidance on several technical issues caused by the interaction of the recently adopted regulatory technical standard on derivatives transparency (RTS 2) and...
US Basel III Endgame 2026 Update
In March 2026, the Board of Governors of the Federal Reserve System, the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation published a new proposal for capital rules known as the US Basel III, based...
Episode 59: Reducing Burdens
As she nears the end of her term as chair of the European Securities and Markets Authority, Verena Ross joins The Swap to discuss progress in simplifying and reducing the burden of EU financial regulation, including transaction reporting. Please view...
